Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
Camilla Krakstad(Haukeland University Hospital), Helga B. Salvesen(Haukeland University Hospital)
Cited by 61
Related Papers
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
|British Journal of Cancer|2012|84
Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
|Communications Medicine|2021|51
Asparaginase‐like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study
|BJOG An International Journal of Obstetrics & Gynaecology|2018|13